Pharos Capital Group has announced it has made an investment in Sanderling Renal Services.

Sanderling, based in Nashville, is a provider of dialysis and renal telemedicine services. The company, which was founded in 2012, provides in-center and home-based dialysis out of 14 clinics in six states, with a focus on communities with limited access to healthcare resources.

Pharos Capital Group, with offices in Dallas and Nashville, pursues control equity and mezzanine investments in lower and middle market companies primarily in healthcare and business services. Founded in 1998, the firm targets the provider services and non-reimbursement industries within healthcare.